Skilling resigns from Enron
Houston: Just six months after this former McKinsey consultant taking over as the chief executive officer and president of the energy giant, Enron Corporation, Jeffrey K Skilling has resigned.

While he has cited personal reasons for the resignation, market watchers state that his resignation follows months of weakness in the energy giants stock price and several high-profile stumbles.

Enron chairman Kenneth Lay will take over as the chief executive of the company, a position he had held for nearly 15 years before Mr. Skilling. With this change, Mr. Lay has extended his employment agreement with Enron through 2005, and told analysts on a conference call that he would use that time to prepare a successor.

Mr. Skilling, who was instrumental in creating Enrons core business in natural gas marketing and trading, also helped in creating the industrys first forward sales contracts and markets. His position, recently, has been marred by the underperformance of the companys much-ballyhooed broadband business, a massive and costly payment fight with the Indian government over Enrons $3-billion Dabhol power plant project and the breakup of a marquee video on-demand broadband internet deal with Blockbuster earlier this year.
Back to News Review index page  

Lele steps down from Parke-Davis
Mumbai: Despite being offered senior strategic positions in the combined entitys global operations, Pramod Lele, chairman and managing director of pharma company Parke Davis stepped down from his positions.

With the company being globally merged with Pfizer, the Indian operations of the two companies are also being merged. Mr. Hocine Sidi Said, managing director of Pfizer, was appointed the new managing director of Parke Davis and noted lawyer RA Shah, currently chairman of Pfizer, will take over as chairman of Parke Davis. Mr. Said will oversee the integration of the two companies in the country.

Mr. Lele's resignation comes in the wake of other senior management positions like IT and human resources being taken charge of by Pfizer managers. World over too, Pfizer's team has reportedly been assigned key management posts.

Mr. Said told shareholders that the operational integration of the two companies would be achieved by the end of this calendar year while the legal merger would probably take till end-2002.
Back to News Review index page  

Raman Pandya quits as managing director of BOC
Kolkata : Raman Pandya, managing director since 1998, who has successfully turned around the fortunes of ailing BOC India, today announced his resignation from the company by end of September.

His place is likely to be filled by Sanjiv Lamba, director in charge of finance function.

According to JN Sapru, the chairman, the resignation is surely to break up the excellent team of the company, but he hoped that professionalism would prevail and the BOC recovery would continue uninterrupted.

Mr. Pandya, who has served BOC India from 1989, including four years at BOC group headquarters in the UK, stated that he has completed his mandate to revive the company and would like to move back into a consumer related business and rejoin his family at Mumbai.
Back to News Review index page